Future Outlook | Learn about STERIS's adjusted guidance, projecting 6-7% revenue growth and 7-10% EPS growth. Analyst price targets range from $231 to $295, averaging around $271. |
Market Dominance | Delve into STERIS's unique position in medical technology, benefiting from non-elective product demand and commanding a premium valuation compared to peers. |
Financial Resilience | Explore STERIS's consistent performance, beating revenue and earnings expectations. AST segment shows double-digit organic growth, driving overall positive results. |
Infection Prevention Giant | STERIS plc leads the market in sterilization and infection control, with a $24.3B market cap and strong financial health, catering to healthcare and pharma industries. |
Metrics to compare | STE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.3x | 27.2x | −0.4x | |
PEG Ratio | 1.00 | 0.15 | 0.00 | |
Price / Book | 2.8x | 2.8x | 2.6x | |
Price / LTM Sales | 3.4x | 2.0x | 3.1x | |
Upside (Analyst Target) | 26.0% | 21.6% | 52.9% | |
Fair Value Upside | Unlock | 28.8% | 6.4% | Unlock |
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.